Giulio Regeni was a scientist like us. We hope his cruel death may serve to focus our attention on the need to respect human rights.
SISSA, the International School for Advanced Studies, was founded in 1978 and is a scientific center of excellence within the national and international academic scene. Located in Italy, in the city of Trieste, it features about 65 professors, approximately a 100 post-docs and 250 PhD students. Situated on the scenic Karst upland, the School is surrounded by a 25 acre park, and offers a stunning view of the Gulf of Trieste.
The three main research areas of SISSA are Physics, Neuroscience and Mathematics.
Quantum computing will be the main topic of a public roundtable hosted by ICTP and SISSA on March 14, featuring high level panellists from IBM and Google as well as a scientist involved in the EC Flagship on Quantum Technologies. The event will take place at the Savoia Excelsior Palace, Trieste.
A new kind of star comes up from a study by SISSA’s postdoctoral researcher Raúl Carballo-Rubio. In a piece of research recently published in Physical Review Letters...
The great adventure which led SISSA to become a prestigious international scientific institution began on 6th March 1978...
A lecture by Karen Vogtmann of Warwick University on the geometrical spaces of finite networks that arise when modeling many phenomena in mathematics and in science.
On Thursday 15 March, world-class researchers in neurodegenerative diseases will share and discuss the latest results on the role of different protein such as Abeta, alpha-synuclein, tau and prion protein in neurodegenerative diseases.
Following the success of the Data Science Proposal for the “Dipartimenti di Eccellenza”, which got funded by MIUR (Ministry of Education, University and Research), SISSA will host a first workshop along this new research direction.
“We are using an experimental approach based on a set of RNA drugs we recently developed in our lab. The aim of this new project is to cast light on specific aspects of this method which still need to be clarified, along a pathway which – in the future – might turn this approach into a cure for patients suffering from Dravet Syndrome”.